Physical Exercise on Metabolic Health, Gut Microbiota, Physical Fitness, and Quality of Life in Obese Breast Cancer Survivors
OBINT
The Impact of Dance Intervention on Metabolic Health, Gut Microbiota, Physical Fitness, and Quality of Life in Obese Breast Cancer Survivors
1 other identifier
interventional
40
1 country
1
Brief Summary
The goal of this clinical trial is to evaluate whether a 3-month dance-based exercise program combined with individualized nutrition can improve health outcomes in obese breast cancer survivors in remission. The main questions it aims to answer are: Will the intervention reduce body weight, body fat, and visceral adiposity? Will it improve cardiorespiratory fitness, motor performance, gut microbiota composition, and quality of life? Researchers will compare women participating in the dance and nutrition program with a control group who maintain their usual lifestyle to see if the intervention leads to favorable metabolic, physical, and microbiome-related changes. Participants will: Attend supervised dance classes three times per week for 12 weeks. Follow an individualized nutrition plan tailored to their resting metabolic rate. Provide blood and stool samples, complete fitness tests, and answer quality-of-life questionnaires before and after the intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedFirst Submitted
Initial submission to the registry
September 22, 2025
CompletedFirst Posted
Study publicly available on registry
October 8, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
ExpectedApril 28, 2026
April 1, 2026
1 year
September 22, 2025
April 25, 2026
Conditions
Outcome Measures
Primary Outcomes (3)
Gut Microbiota Composition (alpha and beta diversity indices)
Evaluated using 16S rRNA sequencing of fecal samples; primary indices include Shannon diversity, Chao1 richness, and Bray-Curtis dissimilarity
Baseline to 12 weeks
Metabolite outcome measures
Systemic inflammation and gut-related metabolites will be assessed by measuring blood biomarkers (hs-CRP, IL-6, TNF-α), fecal inflammatory markers (calprotectin, lactoferrin), and microbiota-derived metabolites including short-chain fatty acids (acetate, propionate, butyrate) in feces and plasma, as well as plasma metabolites such as TMAO and selected bile acids. Intestinal permeability will be evaluated through serum zonulin levels. Together, these measures will provide an integrated view of inflammatory status, microbial metabolic activity, and gut barrier function.
Baseline to 12 weeks
Quality of Life assesment
Change in Quality of Life (EORTC QLQ-C30 Global Health Score) measured using the EORTC QLQ-C30 questionnaire (version 3.0), with scores transformed to a 0-100 scale according to the scoring manual.
Baseline to 12 weeks
Secondary Outcomes (2)
Cardiorespiratory Fitness
Baseline to 12 weeks
Body composition
Baseline to 12 weeks
Study Arms (2)
Dance
EXPERIMENTALThe patients engaged in dance classes two times a week for 3 months
Patients without organized physical exercise
NO INTERVENTIONThe patients engaged in no structured or self-induced physical exercise or activity (sedentary individuals)
Interventions
Participants will attend supervised sessions three times per week, each lasting 60 minutes. Classes were instructed by certified professional dancers and incorporated structured choreographies from three dance genres: folkloric, Latin American, and contemporary.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of breast cancer disease
- At least one year after breast cancer treatment
- Must be able to swallow tablets
- Must be able to folow physical exercise training
You may not qualify if:
- Clinical diagnosis of Parkinson's disease
- Insulin dependent diabetes
- Infectious diseases within the past 2 months
- Use of antibiotics within the past 4 weeks before recruitment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Comenius University in Bratislava, Faculty of physical education and sport
Bratislava, 903 01, Slovakia
Study Officials
- PRINCIPAL INVESTIGATOR
Viktor Bielik, PhD
Comenius University, Faculty of Physical Education and Sport
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- professor
Study Record Dates
First Submitted
September 22, 2025
First Posted
October 8, 2025
Study Start
March 1, 2025
Primary Completion
March 1, 2026
Study Completion (Estimated)
December 31, 2028
Last Updated
April 28, 2026
Record last verified: 2026-04